M Yamamoto Selected Research

M Yamamoto Research Topics

Disease

53	Neoplasms (Cancer) 03/2021 - 01/2000
18	Infections 01/2017 - 01/2000
13	Inflammation (Inflammations) 12/2017 - 01/2000
12	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 01/2000
11	Neoplasm Metastasis (Metastasis) 01/2014 - 01/2000
10	Carcinogenesis 01/2017 - 02/2000
10	Breast Neoplasms (Breast Cancer) 01/2017 - 02/2000
7	Atherosclerosis 04/2014 - 01/2001
6	Obesity 03/2018 - 06/2000
6	Hypertension (High Blood Pressure) 12/2017 - 04/2000
6	Aneurysm (Aneurysms) 08/2017 - 07/2004
6	Type 2 Diabetes Mellitus (MODY) 07/2014 - 12/2007
6	Body Weight (Weight, Body) 07/2014 - 01/2000
6	Necrosis 10/2008 - 02/2000
5	Pain (Aches) 01/2016 - 02/2000
5	Pancreatic Neoplasms (Pancreatic Cancer) 07/2015 - 06/2000
5	Lung Neoplasms (Lung Cancer) 08/2009 - 07/2000
5	Leukemia 05/2007 - 01/2000
4	Esophageal Squamous Cell Carcinoma 03/2021 - 01/2000
4	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 05/2019 - 02/2000
4	Periodontitis 06/2017 - 01/2008
4	Starvation 06/2017 - 06/2000
4	Insulin Resistance 04/2015 - 05/2013
4	Asthma (Bronchial Asthma) 05/2012 - 04/2006
4	Colonic Neoplasms (Colon Cancer) 02/2010 - 07/2000
4	Osteoporosis 11/2009 - 07/2000
4	Fetofetal Transfusion (Twin Transfusion Syndrome) 12/2007 - 05/2006
4	Mikulicz' Disease 09/2006 - 01/2004
4	Melanoma (Melanoma, Malignant) 02/2005 - 02/2001
4	Carcinoma (Carcinomatosis) 01/2001 - 02/2000
3	Sepsis (Septicemia) 09/2021 - 08/2014
3	Esophageal Neoplasms (Esophageal Cancer) 03/2021 - 01/2000
3	Fatty Liver 03/2018 - 06/2000
3	Bacterial Infections (Bacterial Infection) 01/2017 - 12/2012
3	Bone Resorption 08/2016 - 06/2002
3	Wounds and Injuries (Trauma) 11/2015 - 11/2001
3	Liver Diseases (Liver Disease) 04/2014 - 01/2000
3	Disease Progression 12/2013 - 01/2000
3	Prostatic Neoplasms (Prostate Cancer) 03/2013 - 07/2000
3	Hypersensitivity (Allergy) 02/2013 - 03/2001
3	Anemia 07/2010 - 03/2000
3	Fibrosis (Cirrhosis) 01/2010 - 12/2006
3	Sclerosis 08/2009 - 10/2000
3	Ovarian Neoplasms (Ovarian Cancer) 04/2004 - 08/2001
3	Adenocarcinoma 03/2004 - 01/2000

Drug/Important Bio-Agent (IBA)

19	Messenger RNA (mRNA)IBA 05/2012 - 01/2000
17	Proteins (Proteins, Gene)FDA Link 05/2012 - 01/2000
15	CytokinesIBA 02/2016 - 05/2000
10	Immunoglobulin G (IgG)IBA 02/2013 - 01/2000
10	EnzymesIBA 05/2012 - 02/2000
9	Interleukin-6 (Interleukin 6)IBA 01/2017 - 05/2000
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2005 - 01/2000
8	Glucose (Dextrose)FDA LinkGeneric 12/2017 - 06/2000
7	Pharmaceutical PreparationsIBA 01/2017 - 03/2001
6	oxidized low density lipoproteinIBA 06/2017 - 01/2001
6	Transcription Factors (Transcription Factor)IBA 11/2012 - 06/2000
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2005 - 08/2000
6	CholesterolIBA 03/2001 - 03/2000
5	AntibodiesIBA 11/2009 - 02/2000
5	LuciferasesIBA 02/2006 - 08/2000
5	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2001 - 01/2000
4	GlucocorticoidsIBA 09/2021 - 02/2005
4	Immunoglobulins (Immunoglobulin)IBA 05/2019 - 05/2000
4	AntigensIBA 08/2011 - 01/2001
4	Biomarkers (Surrogate Marker)IBA 01/2011 - 02/2000
4	Intravenous Immunoglobulins (IVIG)FDA Link 11/2010 - 05/2000
4	Erythropoietin FDA Link 07/2010 - 09/2000
4	MidkineIBA 12/2001 - 08/2000
4	NF-kappa B (NF-kB)IBA 04/2001 - 01/2000
3	Codon (Codons)IBA 01/2021 - 03/2001
3	Insulin (Novolin)FDA Link 01/2020 - 06/2000
3	LipidsIBA 01/2017 - 01/2000
3	Phosphotransferases (Kinase)IBA 01/2017 - 10/2004
3	Pioglitazone (Actos)FDA Link 07/2014 - 12/2010
3	CarbohydratesIBA 07/2014 - 01/2001
3	VaccinesIBA 04/2014 - 03/2001
3	OsteocalcinIBA 08/2013 - 12/2010
3	Hemoglobins (Hemoglobin)IBA 08/2013 - 07/2000
3	LipopolysaccharidesIBA 03/2013 - 06/2000
3	LDL Lipoproteins (beta Lipoproteins)IBA 03/2013 - 01/2001
3	ChemokinesIBA 12/2012 - 04/2006
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2012 - 09/2001
3	Insulin-Like Growth Factor I (IGF-1)IBA 05/2012 - 12/2007
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2010 - 09/2000
3	Polysaccharides (Glycans)IBA 09/2009 - 01/2000
3	Interleukin-4 (Interleukin 4)IBA 07/2007 - 12/2001
3	Interleukin-1alpha (Interleukin 1 alpha)IBA 11/2006 - 11/2001
3	DNA (Deoxyribonucleic Acid)IBA 07/2004 - 10/2000
3	Capsules (Microcapsules)IBA 07/2004 - 03/2001
3	ImmunosorbentsIBA 01/2004 - 04/2000
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2004 - 08/2001

Therapy/Procedure

29	Therapeutics 09/2021 - 01/2000
10	Drug Therapy (Chemotherapy) 01/2018 - 01/2000
7	Aftercare (After-Treatment) 05/2019 - 02/2000
6	Esophagectomy 03/2021 - 01/2000
5	Stents 08/2017 - 07/2004
3	Oral Administration 01/2017 - 07/2000
3	Immunotherapy 11/2010 - 01/2000
3	Lymph Node Excision (Lymph Node Dissection) 08/2009 - 01/2000
3	Laser Therapy (Surgery, Laser) 12/2007 - 01/2007